These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12543526)

  • 21. Health technology assessment: research trends and future priorities in Europe.
    Nielsen CP; Funch TM; Kristensen FB
    J Health Serv Res Policy; 2011 Jul; 16 Suppl 2():6-15. PubMed ID: 21737525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of dental service data to inform research and policy.
    Whelton H; O'Mullane D; Burke FM; Woods N; Cronin M
    Adv Dent Res; 2005 Dec; 18(3):42-5. PubMed ID: 16385011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving health care systems by building 'more Europe'.
    Antoñanzas F; Juárez-Castelló CA; Rodríguez-Ibeas R
    Eur J Health Econ; 2016 Sep; 17(7):787-9. PubMed ID: 27008028
    [No Abstract]   [Full Text] [Related]  

  • 24. Health technology assessment and health care in the European Union.
    Banta D; Oortwijn W
    Int J Technol Assess Health Care; 2000; 16(2):626-35. PubMed ID: 10932427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [DECIDE: developing and evaluating communication strategies to support informed decisions and practice based on evidence].
    Parmelli E; Amato L; Saitto C; Davoli M;
    Recenti Prog Med; 2013 Oct; 104(10):522-31. PubMed ID: 24326703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Research can be integrated into public health policy-making: global lessons for and from Spanish economic evaluations.
    Trapero-Bertran M; Pokhrel S; Hanney S
    Health Res Policy Syst; 2022 Jun; 20(1):67. PubMed ID: 35717247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What should the government do regarding health policy-making to develop community health care in Shanghai?
    Yu Y; Sun X; Zhuang Y; Dong X; Liu H; Jiang P; Yu Z; Zhang Y
    Int J Health Plann Manage; 2011; 26(4):379-435. PubMed ID: 22213259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. More attention to public health in the European Union - implications for dentistry?
    Widström E; Van Den Heuvel J
    Int Dent J; 2005 Jun; 55(3):157-61. PubMed ID: 15997966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Summary report of the ECHTA/ECAHI project. European Collaboration for Health Technology Assessment/Assessment of Health Interventions.
    Jonsson E; Banta HD; Henshall C; Sampietro-Colom L
    Int J Technol Assess Health Care; 2002; 18(2):218-37. PubMed ID: 12053423
    [No Abstract]   [Full Text] [Related]  

  • 30. Modelling in the economic evaluation of health care: selecting the appropriate approach.
    Barton P; Bryan S; Robinson S
    J Health Serv Res Policy; 2004 Apr; 9(2):110-8. PubMed ID: 15099459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developing specialist healthcare for older people: a challenge for the European Union.
    O Neil D; Hastie I; Williams B
    J Nutr Health Aging; 2004; 8(2):109-12. PubMed ID: 14978606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Best practice in undertaking and reporting health technology assessments. Working group 4 report.
    Velasco M; Perleth M; Drummond M; Gürtner F; Jørgensen T; Jovell A; Malone J; Rüther A; Wild C
    Int J Technol Assess Health Care; 2002; 18(2):361-422. PubMed ID: 12053427
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of research results in policy decision-making, formulation, and implementation: a review of the literature.
    Almeida C; Báscolo E
    Cad Saude Publica; 2006; 22 Suppl():S7-19; discussion S20-33. PubMed ID: 17086340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ECHO: health care performance assessment in several European health systems.
    Bernal-Delgado E; Christiansen T; Bloor K; Mateus C; Yazbeck AM; Munck J; Bremner J;
    Eur J Public Health; 2015 Feb; 25 Suppl 1():3-7. PubMed ID: 25690123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulating the economic evaluation of pharmaceuticals and medical devices: a European perspective.
    Cookson R; Hutton J
    Health Policy; 2003 Feb; 63(2):167-78. PubMed ID: 12543529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Why do health technology assessment coverage recommendations for the same drugs differ across settings? Applying a mixed methods framework to systematically compare orphan drug decisions in four European countries.
    Nicod E
    Eur J Health Econ; 2017 Jul; 18(6):715-730. PubMed ID: 27538758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding frailty: a qualitative study of European healthcare policy-makers' approaches to frailty screening and management.
    Gwyther H; Shaw R; Jaime Dauden EA; D'Avanzo B; Kurpas D; Bujnowska-Fedak M; Kujawa T; Marcucci M; Cano A; Holland C
    BMJ Open; 2018 Jan; 8(1):e018653. PubMed ID: 29331967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pushing the boundaries of evaluation, diffusion, and use of medical devices in Europe: Insights from the COMED project.
    Torbica A; Tarricone R; Schreyögg J; Drummond M
    Health Econ; 2022 Sep; 31 Suppl 1():1-9. PubMed ID: 36068719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Twenty years of health care economic analysis in Spain: are we doing well?
    García-Altés A
    Health Econ; 2001 Dec; 10(8):715-29. PubMed ID: 11747053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Public health research: lessons from the SPHERE project].
    Grimaud O; Clarke A
    Sante Publique; 2008; 20(4):367-70. PubMed ID: 19014088
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.